WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
SynBioBeta 2024: The Global Synthetic Biology Conference
Affiliated Programs
Monday, May 6, 2024 - Thursday, May 9, 2024

San Jose Convention Center
San Jose, CA

Register for event

Wilson Sonsini is proud to sponsor SynBioBeta 2024: The Global Synthetic Biology Conference, where biology becomes the blueprint and human innovation, the artisan. Join us for an unparalleled four-day summit delving into synthetic biology. Explore why the costs of reading, writing, and editing DNA plummet while speed and accessibility soar. Gain insights into cutting-edge medical advancements such as cell therapies, vaccines, and living medicines. Discover how companies harness biology to produce bio-based jet fuel, textiles, concrete, and other chemicals and materials. Engage with trailblazing entrepreneurs crafting innovative foods, crops, and fragrances. Join us to see the potential applications of these technologies in shaping sustainable manufacturing ecosystems.

On Tuesday, May 7th at 1:45pm partner Ian Edvalson will be moderating the panel discussion, Next Frontiers in Nucleic Acid Medicines, and Protein Folding: Unleashing a New Class of Therapeutics, with fellow panelists Raik Grünberg, Research Scientist at KAUST; Chris Gregg, CSO at Gro Biosciences; Taleen Afeyan, Senior Director of Strategy & Operations at Alltrna; Bharath Takulapalli, Founder & CEO of SPOC Proteomics; and Dominique Verhelle, CEO, at Nextrna.    

On Wednesday, May 8th at 1:45pm partner Maya Skubatch will be speaking in a panel presentation, The Arc of Innovation in Generative Protein Design. The promise of generative protein design extends beyond scientific and technological advancements, reaching into the realms of personalized medicine, global health, sustainability, and innovation. As research in this field progresses, it has the potential to reshape our approach to healthcare and biotechnology, offering solutions to challenges that were once considered insurmountable. Anything from enzyme generation to de novo binders to protein logic gates, the promise of in silico structure and function has caught hold. This session will talk about the promise and nuances of advancement in the field.

To view the full event agenda please visit the event website.

Contacts

Katie Stonum

kstonum@wsgr.com

Presenters

Maya Skubatch
Partner
Palo Alto

Maya focuses on strategic patent counseling for healthcare and other technology-driven companies.

View Profile
Ian B. Edvalson
Partner
Palo Alto

Ian advises life sciences clients in strategic alliances, agreements, arrangements, collaborations, and joint ventures.

View Profile
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.